Status:
RECRUITING
Feasibility of End-tidal Oxygen Concentration Monitoring During Preoxygenation for Intubation in the Intensive Care Unit.
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Conditions:
Critically Ill
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Intubation is a common procedure in the intensive care unit. Hypoxemia is the most frequent complication of this procedure. Monitoring the end-tidal of oxygen is recommended in operating room (OR). E...
Detailed Description
This is a prospective non-comparative interventional study. A double monitoring of EtO2 will be performed during the procedure of intubation (from the beginning of the preoxygenation to the success o...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Requiring an intubation in ICU for acute respiratory failure defined as a respiratory rate ≥ 25/min or clinical signs of respiratory distress or hypoxemia defined as oxygen requirement ≥ 15L/min or FiO2 ≥80% to maintain SpO2 ≥92% or a PaO2/FiO2 ratio \<100 mmHg
- With preoxygenation by noninvasive ventilation
Exclusion
- Intubation for cardiac arrest
- EtO2 monitoring not available
- Pulsed oxygen saturation monitoring specific for the study not available
- Preoxygenation by high-flow nasal oxygen therapy or bag-mask ventilation
- Allergy to lidocaine (for local nasal anesthesia)
- Previously
- Patient not affiliated or excluded from social protection, or under law protection (namely minors, pregnant or breastfeeding women, persons deprived of their liberty by court or administrative decision)
- Previously included in the study
Key Trial Info
Start Date :
December 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05409573
Start Date
December 23 2022
End Date
December 1 2025
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR d'ORLEANS
Orléans, France